• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
Mad Hedge Fund Trader

About Mad Hedge Fund Trader

This author has not written his bio yet.
But we are proud to say that Mad Hedge Fund Trader contributed 13681 entries already.

Entries by Mad Hedge Fund Trader

Tech Letter

November 22, 2019

Mad Hedge Technology Letter November 22, 2019 Fiat Lux Featured Trade: (THE REAL STORY BEHIND THE CHARLES SCHWAB/TD AMERITRADE MERGER), (SCHW), (AMTD), (ETFC), (IBKR)

Tech Letter

The Real Story Behind the Charles Schwab/TD Ameritrade Merger

There are certain parts of tech that I routinely bash on like travel tech, music streaming tech, and the usefulness of social media companies. One other group of companies that I’m just as sour on are the discount e-brokers. Yes, tech has embedded deflation into every company causing operations to become more efficient while boosting

Tech Letter

November 22, 2019 - Quote of the Day

“I am so disturbed by kids who spend all day playing videogames.” – Said Co-Founder and CEO of Oracle Larry Ellison

Diary, Newsletter, Summary

November 22, 2019

Global Market Comments November 22, 2019 Fiat Lux Featured Trade: (TRADING THE KENNEDY ASSASSINATION)

MDT Alert

November 21, 2019 - MDT Pro Tips A.M.

While the Diary of a Mad Hedge Fund Trader focuses on investment over a one week to a six-month time frame, Mad Day Trader, provided by Bill Davis, will exploit money-making opportunities over a brief ten minute to three-day window. It is ideally suited for day traders, but can also be used by long-term investors to improve market timing for entry and exit points.

Diary, Newsletter, Summary

November 21, 2019

Global Market Comments November 21, 2019 Fiat Lux SPECIAL TESLA ISSUE Featured Trade: (TESLA TALES), (TSLA)

Diary, Newsletter

Tesla Tales

When a guest asked me to name a clear ten bagger stock for the coming decade at the Mad Hedge Technology Letter, I didn’t hesitate. It was Tesla (TSLA). At long last, investors are perking up and taking notice of the Fremont, California based electric car manufacturer whose shares have been trapped in a highly

Biotech Letter

November 21, 2019

Mad Hedge Biotech & Healthcare Letter November 21, 2019 Fiat Lux Featured Trade: (WHY VERTEX HAS BEEN ON FIRE), (VRTX), (CRSP)

Biotech Letter

Why Vertex has Been on Fire

Vertex Pharmaceuticals Inc. (VRTX) is the unequivocal king of the genetically rare lung condition cystic fibrosis (CF). To further prove its stronghold of the market, the company recently received FDA approval for its fourth CF treatment called Trikafta — five full months ahead of schedule and merely three months following the company’s application. In a

Diary, Newsletter, Quote of the Day

Quote of the Day - November 21, 2019

“Humans are vastly underestimated,” said Tesla founder Elon Musk.  

Page 633 of 1363«‹631632633634635›»

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2026. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
Scroll to top